Invesco Discovery Fund Class A OPOCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$108.91  /  −0.45%
  • Fund Size$6.6B
  • Adjusted Expense Ratio1.030%
  • Net Expense Ratio0.990%
  • Fee Level: DistributionLow
  • Share Class TypeFront Load
  • Morningstar CategorySmall Growth
  • Equity Style Box (Funds)Small Growth
  • Minimum Initial Investment$1,000
  • Investment StatusLimited
  • TTM Yield0.00%
  • Turnover Ratio87%

Morningstar’s Analysis OPOCX

Will OPOCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

An experienced team sporting an impressive record.

Senior Analyst Gregg Wolper

Gregg Wolper

Senior Analyst

Summary

Invesco Discovery’s stable, experienced management team has achieved excellent long-term results with an approach that combines a willingness to pay high prices for fast growers with tactics that mitigate the risks.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OPOCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings21.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Ligand Pharmaceuticals Inc

2.91214M
Healthcare

JFrog Ltd Ordinary Shares

2.47182M
Technology

Repligen Corp

2.35173M
Healthcare

BrightSpring Health Services Inc

2.18160M
Healthcare

Halozyme Therapeutics Inc

2.08153M
Healthcare

Sanmina Corp

1.97145M
Technology

Twist Bioscience Corp

1.97145M
Healthcare

Viavi Solutions Inc

1.88139M
Technology

Chord Energy Corp Ordinary Shares - New

1.88138M
Energy

Littelfuse Inc

1.86137M
Technology

Sponsor Center